754 related articles for article (PubMed ID: 18180250)
1. Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes.
Mihaylova V; Müller JS; Vilchez JJ; Salih MA; Kabiraj MM; D'Amico A; Bertini E; Wölfle J; Schreiner F; Kurlemann G; Rasic VM; Siskova D; Colomer J; Herczegfalvi A; Fabriciova K; Weschke B; Scola R; Hoellen F; Schara U; Abicht A; Lochmüller H
Brain; 2008 Mar; 131(Pt 3):747-59. PubMed ID: 18180250
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of patients with congenital myasthenic syndrome caused by COLQ mutations.
Wargon I; Richard P; Kuntzer T; Sternberg D; Nafissi S; Gaudon K; Lebail A; Bauche S; Hantaï D; Fournier E; Eymard B; Stojkovic T
Neuromuscul Disord; 2012 Apr; 22(4):318-24. PubMed ID: 22088788
[TBL] [Abstract][Full Text] [Related]
3. Synaptic congenital myasthenic syndrome in three patients due to a novel missense mutation (T441A) of the COLQ gene.
Müller JS; Petrova S; Kiefer R; Stucka R; König C; Baumeister SK; Huebner A; Lochmüller H; Abicht A
Neuropediatrics; 2004 Jun; 35(3):183-9. PubMed ID: 15248101
[TBL] [Abstract][Full Text] [Related]
4. Novel COLQ mutation 950delC in synaptic congenital myasthenic syndrome and symptomatic heterozygous relatives.
Schreiner F; Hoppenz M; Klaeren R; Reimann J; Woelfle J
Neuromuscul Disord; 2007 Mar; 17(3):262-5. PubMed ID: 17300939
[TBL] [Abstract][Full Text] [Related]
5. Recurrent COLQ mutation in congenital myasthenic syndrome.
Guven A; Demirci M; Anlar B
Pediatr Neurol; 2012 Apr; 46(4):253-6. PubMed ID: 22490774
[TBL] [Abstract][Full Text] [Related]
6. Clinical and molecular analysis of a novel COLQ missense mutation causing congenital myasthenic syndrome in a Syrian family.
Matlik HN; Milhem RM; Saadeldin IY; Al-Jaibeji HS; Al-Gazali L; Ali BR
Pediatr Neurol; 2014 Jul; 51(1):165-9. PubMed ID: 24938146
[TBL] [Abstract][Full Text] [Related]
7. Congenital endplate acetylcholinesterase deficiency responsive to ephedrine.
Bestue-Cardiel M; Sáenz de Cabezón-Alvarez A; Capablo-Liesa JL; López-Pisón J; Peña-Segura JL; Martin-Martinez J; Engel AG
Neurology; 2005 Jul; 65(1):144-6. PubMed ID: 16009904
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up in patients with congenital myasthenic syndrome due to CHAT mutations.
Schara U; Christen HJ; Durmus H; Hietala M; Krabetz K; Rodolico C; Schreiber G; Topaloglu H; Talim B; Voss W; Pihko H; Abicht A; Müller JS; Lochmüller H
Eur J Paediatr Neurol; 2010 Jul; 14(4):326-33. PubMed ID: 19900826
[TBL] [Abstract][Full Text] [Related]
9. Variable phenotypes associated with mutations in DOK7.
Anderson JA; Ng JJ; Bowe C; McDonald C; Richman DP; Wollmann RL; Maselli RA
Muscle Nerve; 2008 Apr; 37(4):448-56. PubMed ID: 18161030
[TBL] [Abstract][Full Text] [Related]
10. COLQ-Congenital myasthenic syndrome in an Iranian cohort: the clinical and genetics spectrum.
Hesami O; Ramezani M; Ghasemi A; Fatehi F; Okhovat AA; Ziaadini B; Kariminejad A; Nafissi S
Orphanet J Rare Dis; 2024 Mar; 19(1):113. PubMed ID: 38475910
[TBL] [Abstract][Full Text] [Related]
11. [Congenital myasthenic syndromes: difficulties in the diagnosis, course and prognosis, and therapy--The French National Congenital Myasthenic Syndrome Network experience].
Eymard B; Stojkovic T; Sternberg D; Richard P; Nicole S; Fournier E; Béhin A; Laforêt P; Servais L; Romero N; Fardeau M; Hantaï D;
Rev Neurol (Paris); 2013 Feb; 169 Suppl 1():S45-55. PubMed ID: 23452772
[TBL] [Abstract][Full Text] [Related]
12. Neuromuscular junction immaturity and muscle atrophy are hallmarks of the ColQ-deficient mouse, a model of congenital myasthenic syndrome with acetylcholinesterase deficiency.
Sigoillot SM; Bourgeois F; Karmouch J; Molgó J; Dobbertin A; Chevalier C; Houlgatte R; Léger J; Legay C
FASEB J; 2016 Jun; 30(6):2382-99. PubMed ID: 26993635
[TBL] [Abstract][Full Text] [Related]
13. DOK7 congenital myasthenic syndrome.
Palace J
Ann N Y Acad Sci; 2012 Dec; 1275():49-53. PubMed ID: 23278577
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the C-terminal domain of ColQ in endplate acetylcholinesterase deficiency compromise ColQ-MuSK interaction.
Nakata T; Ito M; Azuma Y; Otsuka K; Noguchi Y; Komaki H; Okumura A; Shiraishi K; Masuda A; Natsume J; Kojima S; Ohno K
Hum Mutat; 2013 Jul; 34(7):997-1004. PubMed ID: 23553736
[TBL] [Abstract][Full Text] [Related]
15. Congenital myasthenic syndromes: spotlight on genetic defects of neuromuscular transmission.
Müller JS; Mihaylova V; Abicht A; Lochmüller H
Expert Rev Mol Med; 2007 Aug; 9(22):1-20. PubMed ID: 17686188
[TBL] [Abstract][Full Text] [Related]
16. Ephedrine therapy in eight patients with congenital myasthenic syndrome due to DOK7 mutations.
Schara U; Barisic N; Deschauer M; Lindberg C; Straub V; Strigl-Pill N; Wendt M; Abicht A; Müller JS; Lochmüller H
Neuromuscul Disord; 2009 Dec; 19(12):828-32. PubMed ID: 19837590
[TBL] [Abstract][Full Text] [Related]
17. Viral vector-mediated [corrected] expression of human collagen Q in cultured cells.
Ito M; Masuda A; Jinno S; Katagiri T; Krejci E; Ohno K
Chem Biol Interact; 2008 Sep; 175(1-3):346-8. PubMed ID: 18374322
[TBL] [Abstract][Full Text] [Related]
18. Novel truncating RAPSN mutations causing congenital myasthenic syndrome responsive to 3,4-diaminopyridine.
Banwell BL; Ohno K; Sieb JP; Engel AG
Neuromuscul Disord; 2004 Mar; 14(3):202-7. PubMed ID: 15036330
[TBL] [Abstract][Full Text] [Related]
19. Three novel COLQ mutations and variation of phenotypic expressivity due to G240X.
Shapira YA; Sadeh ME; Bergtraum MP; Tsujino A; Ohno K; Shen XM; Brengman J; Edwardson S; Matoth I; Engel AG
Neurology; 2002 Feb; 58(4):603-9. PubMed ID: 11865139
[TBL] [Abstract][Full Text] [Related]
20. Congenital myasthenic syndromes: current diagnostic and therapeutic approaches.
Schara U; Della Marina A; Abicht A
Neuropediatrics; 2012 Aug; 43(4):184-93. PubMed ID: 22911480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
